X-26194292-A-G
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The ENST00000379034.1(MAGEB6):āc.446A>Gā(p.Gln149Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000103 in 1,207,898 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 35 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
ENST00000379034.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MAGEB6 | NM_173523.2 | c.446A>G | p.Gln149Arg | missense_variant | 2/2 | ENST00000379034.1 | NP_775794.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MAGEB6 | ENST00000379034.1 | c.446A>G | p.Gln149Arg | missense_variant | 2/2 | 1 | NM_173523.2 | ENSP00000368320.1 |
Frequencies
GnomAD3 genomes AF: 0.0000452 AC: 5AN: 110530Hom.: 0 Cov.: 22 AF XY: 0.0000305 AC XY: 1AN XY: 32760
GnomAD3 exomes AF: 0.000169 AC: 31AN: 183448Hom.: 0 AF XY: 0.000147 AC XY: 10AN XY: 67898
GnomAD4 exome AF: 0.000109 AC: 120AN: 1097315Hom.: 0 Cov.: 32 AF XY: 0.0000935 AC XY: 34AN XY: 363471
GnomAD4 genome AF: 0.0000452 AC: 5AN: 110583Hom.: 0 Cov.: 22 AF XY: 0.0000305 AC XY: 1AN XY: 32823
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 06, 2021 | The c.446A>G (p.Q149R) alteration is located in exon 2 (coding exon 1) of the MAGEB6 gene. This alteration results from a A to G substitution at nucleotide position 446, causing the glutamine (Q) at amino acid position 149 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at